Science Explorer Back to mapMap
Discussion
Nonprofit · Trumbull · United States

Rett Syndrome Research Trust

reverserett.orgROR OpenAlex
Research works
1
▲ 2500% vs 2018-21
Citations
52
40.3 per fractional work
Top-10% rate
5.8%
all institutions 10.0%
Open access
91%
world 40%
International
32%
world 18%
Rett Syndrome Research Trust

Not ranked overall: Rett Syndrome Research Trust is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Rett Syndrome Research Trust work in?

In all years, 83% of research at Rett Syndrome Research Trust is in Life Sciences, 8% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (58%), Neuroscience (25%), Medicine (8%). It does 1.3× the world's share of Life Sciences.

Life Sciences: 1 fractional works · 83.3% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 58.3% of its workNeuroscience: 0 fractional works · 25.0% of its workHealth Sciences: 0 fractional works · 8.3% of its workMedicine: 0 fractional works · 8.3% of its workSocial Sciences: 0 fractional works · 8.3% of its workPsychology: 0 fractional works · 8.3% of its workALL ITS WORKRett SyndromeResearch Trust1fractional works, all years
Life Sciences83%Health Sciences8%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology158.3%
    2. Neuroscience025.0%
    1. Medicine08.3%
    1. Psychology08.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Rett Syndrome Research Trust?

The most cited paper from Rett Syndrome Research Trust is "Arbaclofen in fragile X syndrome: results of phase 3 trials" (Elizabeth Berry‐Kravis, Randi Jenssen Hagerman, Jeannie Visootsak et al., 2017), with 186 citations. Next come "Rett Syndrome: Crossing the Threshold to Clinical Translation" (157) and "Consensus guidelines on managing Rett syndrome across the lifespan" (120).

Most cited papers
#PaperReleasedCitations
1 Arbaclofen in fragile X syndrome: results of phase 3 trials Elizabeth Berry‐Kravis, Randi Jenssen Hagerman, Jeannie Visootsak et al. · Journal of Neurodevelopmental Disorders Open access 19 Jan 2017 186
2 Rett Syndrome: Crossing the Threshold to Clinical Translation David Miles Katz, Adrian Peter Bird, Monica Coenraads et al. · Trends in Neurosciences ReviewOpen access 30 Jan 2016 157
3 Consensus guidelines on managing Rett syndrome across the lifespan Cary Fu, Dallas Michael Armstrong, Eric D. Marsh et al. · BMJ Paediatrics Open Open access Sep 2020 120
4 Convergent cerebrospinal fluid proteomes and metabolic ontologies in humans and animal models of Rett syndrome Stephanie A. Zlatic, Duc Minh Duong, Kamal K.E. Gadalla et al. · iScience Open access 17 Aug 2022 16
5 Systemic proteome phenotypes reveal defective metabolic flexibility in Mecp2 mutants Stephanie A. Zlatic, Erica Werner, Veda Surapaneni et al. · Human Molecular Genetics Open access 13 Sep 2023 13
All 15 most cited papers, with filters and sorting

Which research topics does Rett Syndrome Research Trust publish most on?

By volume in 2022-now: Genetics and Neurodevelopmental Disorders, Autism Spectrum Disorder Research, RNA regulation and disease and RNA modifications and cancer.

Genetics and Neurodevelo…0Genetics and Neurodevelopmental Disorders: 0 fractional worksAutism Spectrum Disorder…0Autism Spectrum Disorder Research: 0 fractional worksRNA regulation and disease0RNA regulation and disease: 0 fractional worksRNA modifications and ca…0RNA modifications and cancer: 0 fractional worksFamily and Disability Support Research: 0 fractional works
GeneticsCognitive NeuroscienceMolecular BiologyClinical Psychology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetics and Neurodevelopmental Disorders Genetics 0 works
  2. 2 Autism Spectrum Disorder Research Cognitive Neuroscience 0 works
  3. 3 RNA regulation and disease Molecular Biology 0 works
  4. 4 RNA modifications and cancer Molecular Biology 0 works
  5. 5 Family and Disability Support Research Clinical Psychology 0 works
  6. 6 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
  7. 7 Anesthesia and Neurotoxicity Research Developmental Neuroscience 0 works
  8. 8 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
  9. 9 Ubiquitin and proteasome pathways Molecular Biology 0 works
  10. 10 Treatment of Major Depression Pharmacology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available91.2%not open8.8%

World: 40% of research is openly available.

with international co-authors31.9%domestic only68.1%

World: 18% is written across borders.

How has Rett Syndrome Research Trust's research output changed?

Output in 2022-2025 was 2500% higher than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Trumbull

All research institutions in Trumbull

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Rett Syndrome Research Trust. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.